Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

248. Treatment of Antimicrobial-Resistant Infections: Saturday, 12:15 - 1:30 p.m.

Poster Session: Treatment of Antimicrobial-Resistant Infections

(2812) Clinical Impact of the Ceftolozane-Tazobactam Shortage on Difficult-To-Treat Resistant Pseudomonas aeruginosa Infections at an Academic Medical Center

Saturday, October 14, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C

    Presenting Author(s)

  • Mary K. Vance, PharmD

    Infectious Diseases Pharmacy Coordinator
    Arkansas Children's Hospital
    Little Rock, Arkansas, United States

    • Co-Author(s)

  • CC

    Christo Cimino, PharmD, BCPS, BCIDP

    Clinical Pharmacy Specialist, Infectious Diseases
    Vanderbilt University Medical Center
    Nashville, Tennessee, United States

  • BE

    Benjamin Ereshefsky, PharmD

    Vanderbilt University Medical Center
    Nashville, Tennessee, United States

  • Romney Humphries, PhD, D(ABMM), M(ASCP)

    Division Director, Laboratory Medicine
    Vanderbilt University Medical Center
    Nashville, Tennessee, United States

  • GN

    George E. Nelson, MD

    Associate Professor; Director of Antimicrobial Stewardship; Associate Hospital Epidemiologist
    Vanderbilt University Medical Center
    Nashville, Tennessee, United States